An experimental study on cervix cancer with combination of HSV-TK/GCV suicide gene therapy system and 60Co radiotherapy

被引：0
|
作者：
Daozhen Chen
Qiusha Tang
机构：
[1] Wuxi Hospital for Matemaland Child Health Care Affiliated Nanjing Medical University,Clinical Laboratory
[2] Southeast University,School of Clinical Medical Science
来源：
BMC Cancer | / 10卷
关键词：
Radiotherapy Group; Suicide Gene; Combine Treatment Group; Absorption Dose; Suicide Gene Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] An experimental study on cervix cancer with combination of HSV-TK/GCV suicide gene therapy system and 60Co radiotherapy
    Chen, Daozhen
    Tang, Qiusha
    BMC CANCER, 2010, 10
  • [2] HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector
    Wang, Yuhua
    Canine, Brenda F.
    Hatefi, Arash
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2011, 7 (02) : 193 - 200
  • [3] Efficacy of HSV-TK/GCV system suicide gene therapy using SHED expressing modified HSV-TK against lung cancer brain metastases
    Oishi, Tomoya
    Ito, Masahiko
    Koizumi, Shinichiro
    Horikawa, Makoto
    Yamamoto, Taisuke
    Yamagishi, Satoru
    Yamasaki, Tomohiro
    Sameshima, Tetsuro
    Suzuki, Tetsuro
    Sugimura, Haruhiko
    Namba, Hiroki
    Kurozumil, Kazuhiko
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 26 : 253 - 265
  • [4] Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer
    Tang, Qiusha
    Zhang, Dongsheng
    Wan, Meilin
    Jin, Liqiang
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (06) : 755 - 761
  • [5] Assessments for prediction of bystander effect in HSV-tk/GCV gene therapy
    Kenmochi, Hiroaki
    Yamasaki, Tomohiro
    Namba, Hiroki
    CANCER SCIENCE, 2018, 109 : 252 - 252
  • [6] ASSESSMENTS FOR PREDICTION OF BYSTANDER EFFECT IN HSV-TK/GCV GENE THERAPY
    Kenmochi, H.
    Yamasaki, T.
    Horikawa, M.
    Yamamoto, T.
    Koizumi, S.
    Sameshima, T.
    Namba, H.
    NEURO-ONCOLOGY, 2018, 20 : 295 - 295
  • [7] Killing activity of HSV-TK/GCV suicide gene therapy for cancer stem cells derived from malignant glioma
    Shimizu, Keiji
    Yawata, Toshio
    Nakai, Eiichi
    Toyonaga, Shinichi
    Chihara, Takahiro
    Maeda, Yusuke
    Okiku, Makiko
    Masahira, Noritaka
    Ikenaka, Kazuhiro
    JOURNAL OF GENE MEDICINE, 2007, 9 (06): : 532 - 532
  • [8] IMMUNOGENIC AND IMMUNOSUPPRESSIVE ASPECTS OF HSV-TK/GCV-MEDIATED SUICIDE GENE THERAPY IN GLIOMA CELLS
    Hossain, Jubayer
    Latif, Abdul
    Chaudhuri, Romi
    Solel, Ege
    Ystaas, Lars
    Bjerkvig, Rolf
    Miletic, Hrvoje
    NEURO-ONCOLOGY, 2023, 25
  • [9] The HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme
    Adachi, N
    Könü, DL
    Frei, K
    Yonekawa, Y
    NEUROLOGICAL SURGERY, 2000, 28 (10): : 865 - 871
  • [10] Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system
    Bai, SC
    Du, LP
    Liu, WQ
    Whittle, IR
    He, L
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (02) : 455 - 459
12345